eHealthMe - Personalized health information & community eHealthMe - Personalized health information & community

Personalized health information & community


All drugs: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
All conditions: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Check symptoms   -   Check drugs   -   Compare drugs   -   Join a support group   -   More tools

Review: taking Celebrex and Methylprednisolone together

Summary: drug interactions are reported among people who take Celebrex and Methylprednisolone together.

This review analyzes the effectiveness and drug interactions between Celebrex and Methylprednisolone. It is created by eHealthMe based on reports of 413 people who take the same drugs from FDA and social media, and is updated regularly.

 

You are not alone: join a support group for people who take Celebrex and Methylprednisolone >>>

On Mar, 6, 2015: 413 people who take Celebrex, Methylprednisolone are studied

Celebrex, Methylprednisolone outcomes

Drug combinations in study:
- Celebrex (celecoxib)
- Methylprednisolone (methylprednisolone)

Drug effectiveness over time :

< 1 month1 - 6 months6 - 12 months1 - 2 years2 - 5 years5 - 10 years10+ yearsnot specified
Celebrex is effective0.00%
(0 of 1 people)
n/an/a0.00%
(0 of 1 people)
n/an/an/an/a
Methylprednisolone is effectiven/a0.00%
(0 of 1 people)
n/an/an/an/an/an/a

Drug effectiveness by gender :

FemaleMale
Celebrex is effective0.00%
(0 of 2 people)
n/a
Methylprednisolone is effective0.00%
(0 of 1 people)
n/a

Drug effectiveness by age :

0-12-910-1920-2930-3940-4950-5960+
Celebrex is effectiven/an/an/a0.00%
(0 of 2 people)
0.00%
(0 of 1 people)
n/an/an/a
Methylprednisolone is effectiven/an/an/an/a0.00%
(0 of 1 people)
n/an/an/a

Most common drug interactions over time * :

< 1 month1 - 6 months6 - 12 months1 - 2 years2 - 5 years5 - 10 years10+ yearsnot specified
Stevens-johnson SyndromeAsthmaCoronary Artery DiseasePneumocystis Jiroveci PneumoniaSudden DeathPneumocystis Jiroveci PneumoniaPeriarthritisAnxiety
Demyelinating PolyneuropathyAspartate Aminotransferase IncreasedSudden DeathSwellingThrombosisSudden DeathPain
ArthralgiaBlood Alkaline Phosphatase IncreasedHypersomniaDrug HypersensitivitySchizophreniaPulmonary EmbolismInsomnia
SinusitisDermatitis ContactSomnolenceJoint InstabilityPanic AttackDeep Vein ThrombosisDyspnoea
Alanine Aminotransferase IncreasedGamma-glutamyltransferase IncreasedRheumatoid ArthritisPanic AttackMyocardial InfarctionCardiac Failure CongestiveDepression
FolliculitisDiarrhoeaAstheniaIntestinal IschaemiaCardiovascular DisorderBronchitis
Myocardial InfarctionAlanine Aminotransferase IncreasedCondition AggravatedOptic Neuritis RetrobulbarThrombosisArthralgia
Throat LesionAstheniaDepressionIntestinal IschaemiaBack Pain
Erythema MultiformeWeight DecreasedDemyelinationDrug Ineffective
EczemaFractureAnxietyAnaemia

Most common drug interactions by gender * :

FemaleMale
AnxietyAnxiety
ArthralgiaPain
PainDrug Ineffective
InsomniaDyspnoea
AnaemiaInsomnia
DepressionAsthenia
BronchitisBack Pain
DyspnoeaDisability
OsteomyelitisFall
Back PainIntervertebral Disc Protrusion

Most common drug interactions by age * :

0-12-910-1920-2930-3940-4950-5960+
n/an/an/aPainAlanine Aminotransferase IncreasedDrug IneffectiveInsomniaAnxiety
Intestinal ObstructionAspartate Aminotransferase IncreasedDepressionArthralgiaOsteonecrosis Of Jaw
Drug DependenceGamma-glutamyltransferase IncreasedInsomniaDepressionPain
Drug Withdrawal SyndromeDrug IneffectiveDyspnoeaHeadacheBack Pain
Drug AbuserHepatic Enzyme IncreasedBronchitisFatigueIntervertebral Disc Protrusion
Suicide AttemptFacial PalsyAnxietyAnaemiaTooth Infection
Personality DisorderPancreatitis AcuteFallPainOsteoarthritis
Urinary RetentionHyperamylasaemiaNauseaAnxietyOsteomyelitis
Abdominal Pain UpperDemyelinationAnaemiaDizzinessPain In Jaw
Pulmonary EmbolismLipase IncreasedHip FractureEmotional DistressDyspnoea

* Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Celebrex and Methylprednisolone?

 

 

 

You are not alone! Join a related support group:
- support group for people who take Celebrex
- support group for people who take Methylprednisolone

Recent related drug studies (Check your drugs):

Complete drug side effects:

On eHealthMe, Celebrex (celecoxib) is often used to treat arthritis. Methylprednisolone (methylprednisolone) is often used to treat inflammation. Find out below the conditions the drugs are used for, how effective they are, and any alternative drugs that you can use to treat those same conditions.

What is the drug used for and how effective is it:

Other drugs that are used to treat the same conditions:

NOTE: The study is based on active ingredients. Other drugs that have the same active ingredients are also considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

   

About - Terms of service - Privacy policy - Press - Testimonials - Contact us - eHealth.me

 
© 2015 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.